Mendes S.R.L.
Records under this name other than patents Mendes S.R.L. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,065,200 | Mucoadhesive devices for the release of probiotics and for the maintenance of their enzyme activities Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 12,246,088 | Mucoadhesive devices for the release of probiotics and for the maintenance of their enzyme activities Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 6,572,854 | Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria Formerly held Term ended Term ended Aug 3, 2020 · From the USPTO record | Term ended | Term ended Aug 3, 2020 | From the USPTO record |
| US 6,544,568 | Symbiotic functional food containing lactic acid bacteria Formerly held Term ended Term ended Dec 15, 2019 · From the USPTO record | Term ended | Term ended Dec 15, 2019 | From the USPTO record |
| US 7,147,847 | Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria Formerly held Lapsed on the fee record Ended Dec 12, 2018 · From the USPTO record | Lapsed on the fee record | Ended Dec 12, 2018 | From the USPTO record |
| US 7,142,243 | Image Sensing Apparatus Having a Member That Adjusts with Temperature Change Formerly held Lapsed on the fee record Ended Nov 28, 2018 · High confidence | Lapsed on the fee record | Ended Nov 28, 2018 | High confidence |
| US 6,410,019 | Use of G class immunoglobulins for the topical treatment of atopic dermatitis Formerly held Lapsed on the fee record Ended Jun 25, 2014 · From the USPTO record | Lapsed on the fee record | Ended Jun 25, 2014 | From the USPTO record |
| US 6,380,252 | Use of L-acetylcarnitine, L-isovalerylcarnitine, L-propionylcarnitine for increasing the levels of IGF-1 Lapsed on the fee record Ended Apr 30, 2014 · From the USPTO record | Lapsed on the fee record | Ended Apr 30, 2014 | From the USPTO record |
| US 6,350,782 | Use of basic amino acids derivatives for lowering ceramide levels Lapsed on the fee record Ended Feb 26, 2014 · From the USPTO record | Lapsed on the fee record | Ended Feb 26, 2014 | From the USPTO record |
| US 6,166,077 | Use of L-acetylcarnitine, L-isovalerylcarnitine, L-propionylcarnitine for increasing the levels of IGF-1 Lapsed on the fee record Ended Dec 26, 2012 · From the USPTO record | Lapsed on the fee record | Ended Dec 26, 2012 | From the USPTO record |